nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—Ethinyl Estradiol—prostate cancer	0.0947	0.177	CbGbCtD
Levetiracetam—ABCC2—Conjugated Estrogens—prostate cancer	0.0695	0.13	CbGbCtD
Levetiracetam—ABCB1—Estramustine—prostate cancer	0.0537	0.1	CbGbCtD
Levetiracetam—ABCC2—Etoposide—prostate cancer	0.0398	0.0743	CbGbCtD
Levetiracetam—ABCC2—Docetaxel—prostate cancer	0.0364	0.068	CbGbCtD
Levetiracetam—ABCB1—Cabazitaxel—prostate cancer	0.0354	0.0661	CbGbCtD
Levetiracetam—ABCB1—Estrone—prostate cancer	0.0346	0.0646	CbGbCtD
Levetiracetam—ABCB1—Ethinyl Estradiol—prostate cancer	0.0309	0.0576	CbGbCtD
Levetiracetam—ABCC2—Doxorubicin—prostate cancer	0.0272	0.0507	CbGbCtD
Levetiracetam—ABCB1—Conjugated Estrogens—prostate cancer	0.0227	0.0422	CbGbCtD
Levetiracetam—ABCB1—Mitoxantrone—prostate cancer	0.0206	0.0384	CbGbCtD
Levetiracetam—ABCB1—Estradiol—prostate cancer	0.0199	0.0371	CbGbCtD
Levetiracetam—ABCB1—Prednisone—prostate cancer	0.0171	0.0319	CbGbCtD
Levetiracetam—ABCB1—Etoposide—prostate cancer	0.013	0.0242	CbGbCtD
Levetiracetam—ABCB1—Docetaxel—prostate cancer	0.0119	0.0222	CbGbCtD
Levetiracetam—SV2A—prostate gland—prostate cancer	0.0111	0.21	CbGeAlD
Levetiracetam—SV2A—seminal vesicle—prostate cancer	0.0094	0.177	CbGeAlD
Levetiracetam—ABCB1—Doxorubicin—prostate cancer	0.00886	0.0165	CbGbCtD
Levetiracetam—SV2A—urethra—prostate cancer	0.00744	0.14	CbGeAlD
Levetiracetam—SV2A—testis—prostate cancer	0.0049	0.0924	CbGeAlD
Levetiracetam—SV2A—lymph node—prostate cancer	0.00355	0.067	CbGeAlD
Levetiracetam—CACNA1B—testis—prostate cancer	0.00338	0.0639	CbGeAlD
Levetiracetam—ABCC2—prostate gland—prostate cancer	0.00249	0.047	CbGeAlD
Levetiracetam—CACNA1B—lymph node—prostate cancer	0.00245	0.0463	CbGeAlD
Levetiracetam—ABCC2—renal system—prostate cancer	0.0017	0.032	CbGeAlD
Levetiracetam—ABCC2—testis—prostate cancer	0.0011	0.0207	CbGeAlD
Levetiracetam—ABCB1—prostate gland—prostate cancer	0.000894	0.0169	CbGeAlD
Levetiracetam—ABCC2—lymph node—prostate cancer	0.000794	0.015	CbGeAlD
Levetiracetam—ABCB1—seminal vesicle—prostate cancer	0.000757	0.0143	CbGeAlD
Levetiracetam—ABCB1—epithelium—prostate cancer	0.000657	0.0124	CbGeAlD
Levetiracetam—ABCB1—renal system—prostate cancer	0.00061	0.0115	CbGeAlD
Levetiracetam—ABCB1—urethra—prostate cancer	0.000599	0.0113	CbGeAlD
Levetiracetam—ABCB1—bone marrow—prostate cancer	0.000461	0.0087	CbGeAlD
Levetiracetam—ABCB1—testis—prostate cancer	0.000394	0.00744	CbGeAlD
Levetiracetam—ABCB1—lymph node—prostate cancer	0.000286	0.00539	CbGeAlD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—prostate cancer	7.86e-05	0.00045	CbGpPWpGaD
Levetiracetam—SV2A—Disease—LPL—prostate cancer	7.85e-05	0.00045	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—NCOA1—prostate cancer	7.84e-05	0.000449	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PDGFRB—prostate cancer	7.78e-05	0.000446	CbGpPWpGaD
Levetiracetam—Upper respiratory tract infection—Doxorubicin—prostate cancer	7.68e-05	0.000325	CcSEcCtD
Levetiracetam—Myalgia—Capecitabine—prostate cancer	7.6e-05	0.000322	CcSEcCtD
Levetiracetam—Chest pain—Capecitabine—prostate cancer	7.6e-05	0.000322	CcSEcCtD
Levetiracetam—Arthralgia—Capecitabine—prostate cancer	7.6e-05	0.000322	CcSEcCtD
Levetiracetam—Confusional state—Docetaxel—prostate cancer	7.59e-05	0.000321	CcSEcCtD
Levetiracetam—Anxiety—Capecitabine—prostate cancer	7.58e-05	0.000321	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	7.55e-05	0.00032	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Epirubicin—prostate cancer	7.53e-05	0.000319	CcSEcCtD
Levetiracetam—SV2A—Disease—ERCC2—prostate cancer	7.52e-05	0.000431	CbGpPWpGaD
Levetiracetam—Weight increased—Doxorubicin—prostate cancer	7.52e-05	0.000318	CcSEcCtD
Levetiracetam—Epistaxis—Epirubicin—prostate cancer	7.51e-05	0.000318	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—CXCL12—prostate cancer	7.51e-05	0.00043	CbGpPWpGaD
Levetiracetam—Vision blurred—Prednisone—prostate cancer	7.5e-05	0.000317	CcSEcCtD
Levetiracetam—Infection—Docetaxel—prostate cancer	7.48e-05	0.000317	CcSEcCtD
Levetiracetam—Weight decreased—Doxorubicin—prostate cancer	7.47e-05	0.000316	CcSEcCtD
Levetiracetam—Sinusitis—Epirubicin—prostate cancer	7.47e-05	0.000316	CcSEcCtD
Levetiracetam—Feeling abnormal—Etoposide—prostate cancer	7.46e-05	0.000316	CcSEcCtD
Levetiracetam—Diarrhoea—Mitoxantrone—prostate cancer	7.45e-05	0.000315	CcSEcCtD
Levetiracetam—Vomiting—Estradiol—prostate cancer	7.43e-05	0.000315	CcSEcCtD
Levetiracetam—Agranulocytosis—Epirubicin—prostate cancer	7.43e-05	0.000315	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Etoposide—prostate cancer	7.41e-05	0.000314	CcSEcCtD
Levetiracetam—ABCC2—NRF2 pathway—GSTM1—prostate cancer	7.4e-05	0.000424	CbGpPWpGaD
Levetiracetam—Nervous system disorder—Docetaxel—prostate cancer	7.38e-05	0.000313	CcSEcCtD
Levetiracetam—Thrombocytopenia—Docetaxel—prostate cancer	7.37e-05	0.000312	CcSEcCtD
Levetiracetam—Rash—Estradiol—prostate cancer	7.37e-05	0.000312	CcSEcCtD
Levetiracetam—Drowsiness—Doxorubicin—prostate cancer	7.37e-05	0.000312	CcSEcCtD
Levetiracetam—Infestation NOS—Doxorubicin—prostate cancer	7.37e-05	0.000312	CcSEcCtD
Levetiracetam—Infestation—Doxorubicin—prostate cancer	7.37e-05	0.000312	CcSEcCtD
Levetiracetam—Dermatitis—Estradiol—prostate cancer	7.36e-05	0.000312	CcSEcCtD
Levetiracetam—SV2A—Disease—ERBB3—prostate cancer	7.36e-05	0.000421	CbGpPWpGaD
Levetiracetam—Confusional state—Capecitabine—prostate cancer	7.35e-05	0.000311	CcSEcCtD
Levetiracetam—SV2A—Disease—FGFR2—prostate cancer	7.34e-05	0.00042	CbGpPWpGaD
Levetiracetam—Headache—Estradiol—prostate cancer	7.32e-05	0.00031	CcSEcCtD
Levetiracetam—Skin disorder—Docetaxel—prostate cancer	7.31e-05	0.00031	CcSEcCtD
Levetiracetam—Agitation—Prednisone—prostate cancer	7.31e-05	0.000309	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	7.3e-05	0.000309	CcSEcCtD
Levetiracetam—Infection—Capecitabine—prostate cancer	7.24e-05	0.000307	CcSEcCtD
Levetiracetam—Stomatitis—Doxorubicin—prostate cancer	7.18e-05	0.000304	CcSEcCtD
Levetiracetam—Anorexia—Docetaxel—prostate cancer	7.17e-05	0.000304	CcSEcCtD
Levetiracetam—Rhinitis—Epirubicin—prostate cancer	7.16e-05	0.000303	CcSEcCtD
Levetiracetam—Body temperature increased—Etoposide—prostate cancer	7.16e-05	0.000303	CcSEcCtD
Levetiracetam—Abdominal pain—Etoposide—prostate cancer	7.16e-05	0.000303	CcSEcCtD
Levetiracetam—Conjunctivitis—Doxorubicin—prostate cancer	7.16e-05	0.000303	CcSEcCtD
Levetiracetam—Urinary tract infection—Doxorubicin—prostate cancer	7.16e-05	0.000303	CcSEcCtD
Levetiracetam—Nervous system disorder—Capecitabine—prostate cancer	7.15e-05	0.000303	CcSEcCtD
Levetiracetam—Vertigo—Prednisone—prostate cancer	7.15e-05	0.000303	CcSEcCtD
Levetiracetam—Hepatitis—Epirubicin—prostate cancer	7.15e-05	0.000303	CcSEcCtD
Levetiracetam—Thrombocytopenia—Capecitabine—prostate cancer	7.14e-05	0.000302	CcSEcCtD
Levetiracetam—Pharyngitis—Epirubicin—prostate cancer	7.09e-05	0.0003	CcSEcCtD
Levetiracetam—Skin disorder—Capecitabine—prostate cancer	7.08e-05	0.0003	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—CASP9—prostate cancer	7.07e-05	0.000405	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MTHFR—prostate cancer	7.07e-05	0.000405	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—prostate cancer	7.05e-05	0.000404	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TERT—prostate cancer	7.05e-05	0.000404	CbGpPWpGaD
Levetiracetam—Connective tissue disorder—Epirubicin—prostate cancer	7.02e-05	0.000297	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Doxorubicin—prostate cancer	6.97e-05	0.000295	CcSEcCtD
Levetiracetam—Epistaxis—Doxorubicin—prostate cancer	6.95e-05	0.000294	CcSEcCtD
Levetiracetam—Anorexia—Capecitabine—prostate cancer	6.95e-05	0.000294	CcSEcCtD
Levetiracetam—Nausea—Estradiol—prostate cancer	6.94e-05	0.000294	CcSEcCtD
Levetiracetam—Vomiting—Mitoxantrone—prostate cancer	6.92e-05	0.000293	CcSEcCtD
Levetiracetam—Sinusitis—Doxorubicin—prostate cancer	6.91e-05	0.000293	CcSEcCtD
Levetiracetam—Convulsion—Prednisone—prostate cancer	6.89e-05	0.000292	CcSEcCtD
Levetiracetam—Agranulocytosis—Doxorubicin—prostate cancer	6.87e-05	0.000291	CcSEcCtD
Levetiracetam—Rash—Mitoxantrone—prostate cancer	6.87e-05	0.000291	CcSEcCtD
Levetiracetam—Dermatitis—Mitoxantrone—prostate cancer	6.86e-05	0.00029	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Docetaxel—prostate cancer	6.86e-05	0.00029	CcSEcCtD
Levetiracetam—Headache—Mitoxantrone—prostate cancer	6.82e-05	0.000289	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	6.81e-05	0.00039	CbGpPWpGaD
Levetiracetam—Insomnia—Docetaxel—prostate cancer	6.81e-05	0.000288	CcSEcCtD
Levetiracetam—Arthralgia—Prednisone—prostate cancer	6.77e-05	0.000287	CcSEcCtD
Levetiracetam—Myalgia—Prednisone—prostate cancer	6.77e-05	0.000287	CcSEcCtD
Levetiracetam—Paraesthesia—Docetaxel—prostate cancer	6.76e-05	0.000286	CcSEcCtD
Levetiracetam—Erythema multiforme—Epirubicin—prostate cancer	6.76e-05	0.000286	CcSEcCtD
Levetiracetam—Anxiety—Prednisone—prostate cancer	6.75e-05	0.000286	CcSEcCtD
Levetiracetam—SV2A—Disease—HIF1A—prostate cancer	6.74e-05	0.000386	CbGpPWpGaD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	6.73e-05	0.000285	CcSEcCtD
Levetiracetam—Somnolence—Docetaxel—prostate cancer	6.69e-05	0.000283	CcSEcCtD
Levetiracetam—Eye disorder—Epirubicin—prostate cancer	6.68e-05	0.000283	CcSEcCtD
Levetiracetam—Hypersensitivity—Etoposide—prostate cancer	6.67e-05	0.000283	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	6.64e-05	0.00038	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	6.64e-05	0.00038	CbGpPWpGaD
Levetiracetam—Musculoskeletal discomfort—Capecitabine—prostate cancer	6.64e-05	0.000281	CcSEcCtD
Levetiracetam—Rhinitis—Doxorubicin—prostate cancer	6.63e-05	0.000281	CcSEcCtD
Levetiracetam—Dyspepsia—Docetaxel—prostate cancer	6.63e-05	0.000281	CcSEcCtD
Levetiracetam—Hepatitis—Doxorubicin—prostate cancer	6.61e-05	0.00028	CcSEcCtD
Levetiracetam—Insomnia—Capecitabine—prostate cancer	6.59e-05	0.000279	CcSEcCtD
Levetiracetam—Pharyngitis—Doxorubicin—prostate cancer	6.56e-05	0.000278	CcSEcCtD
Levetiracetam—Paraesthesia—Capecitabine—prostate cancer	6.54e-05	0.000277	CcSEcCtD
Levetiracetam—Decreased appetite—Docetaxel—prostate cancer	6.54e-05	0.000277	CcSEcCtD
Levetiracetam—SV2A—Disease—CAV1—prostate cancer	6.52e-05	0.000373	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Docetaxel—prostate cancer	6.5e-05	0.000275	CcSEcCtD
Levetiracetam—Asthenia—Etoposide—prostate cancer	6.5e-05	0.000275	CcSEcCtD
Levetiracetam—Connective tissue disorder—Doxorubicin—prostate cancer	6.5e-05	0.000275	CcSEcCtD
Levetiracetam—Fatigue—Docetaxel—prostate cancer	6.49e-05	0.000275	CcSEcCtD
Levetiracetam—Nausea—Mitoxantrone—prostate cancer	6.47e-05	0.000274	CcSEcCtD
Levetiracetam—Immune system disorder—Epirubicin—prostate cancer	6.45e-05	0.000273	CcSEcCtD
Levetiracetam—Infection—Prednisone—prostate cancer	6.45e-05	0.000273	CcSEcCtD
Levetiracetam—Mediastinal disorder—Epirubicin—prostate cancer	6.44e-05	0.000273	CcSEcCtD
Levetiracetam—Constipation—Docetaxel—prostate cancer	6.44e-05	0.000273	CcSEcCtD
Levetiracetam—Pain—Docetaxel—prostate cancer	6.44e-05	0.000273	CcSEcCtD
Levetiracetam—Dyspepsia—Capecitabine—prostate cancer	6.42e-05	0.000272	CcSEcCtD
Levetiracetam—Pruritus—Etoposide—prostate cancer	6.41e-05	0.000271	CcSEcCtD
Levetiracetam—Nervous system disorder—Prednisone—prostate cancer	6.37e-05	0.00027	CcSEcCtD
Levetiracetam—Decreased appetite—Capecitabine—prostate cancer	6.34e-05	0.000268	CcSEcCtD
Levetiracetam—Alopecia—Epirubicin—prostate cancer	6.31e-05	0.000267	CcSEcCtD
Levetiracetam—Skin disorder—Prednisone—prostate cancer	6.31e-05	0.000267	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Capecitabine—prostate cancer	6.29e-05	0.000266	CcSEcCtD
Levetiracetam—Fatigue—Capecitabine—prostate cancer	6.28e-05	0.000266	CcSEcCtD
Levetiracetam—Mental disorder—Epirubicin—prostate cancer	6.26e-05	0.000265	CcSEcCtD
Levetiracetam—Erythema multiforme—Doxorubicin—prostate cancer	6.25e-05	0.000265	CcSEcCtD
Levetiracetam—Pain—Capecitabine—prostate cancer	6.23e-05	0.000264	CcSEcCtD
Levetiracetam—Constipation—Capecitabine—prostate cancer	6.23e-05	0.000264	CcSEcCtD
Levetiracetam—Malnutrition—Epirubicin—prostate cancer	6.22e-05	0.000263	CcSEcCtD
Levetiracetam—Feeling abnormal—Docetaxel—prostate cancer	6.2e-05	0.000263	CcSEcCtD
Levetiracetam—Diarrhoea—Etoposide—prostate cancer	6.2e-05	0.000262	CcSEcCtD
Levetiracetam—Anorexia—Prednisone—prostate cancer	6.19e-05	0.000262	CcSEcCtD
Levetiracetam—Eye disorder—Doxorubicin—prostate cancer	6.18e-05	0.000262	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Docetaxel—prostate cancer	6.16e-05	0.000261	CcSEcCtD
Levetiracetam—SV2A—Disease—BAD—prostate cancer	6.13e-05	0.000351	CbGpPWpGaD
Levetiracetam—Tension—Epirubicin—prostate cancer	6.1e-05	0.000258	CcSEcCtD
Levetiracetam—Nervousness—Epirubicin—prostate cancer	6.04e-05	0.000256	CcSEcCtD
Levetiracetam—Back pain—Epirubicin—prostate cancer	6.02e-05	0.000255	CcSEcCtD
Levetiracetam—Feeling abnormal—Capecitabine—prostate cancer	6.01e-05	0.000254	CcSEcCtD
Levetiracetam—Dizziness—Etoposide—prostate cancer	5.99e-05	0.000254	CcSEcCtD
Levetiracetam—Immune system disorder—Doxorubicin—prostate cancer	5.97e-05	0.000253	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Capecitabine—prostate cancer	5.96e-05	0.000252	CcSEcCtD
Levetiracetam—Mediastinal disorder—Doxorubicin—prostate cancer	5.96e-05	0.000252	CcSEcCtD
Levetiracetam—Body temperature increased—Docetaxel—prostate cancer	5.95e-05	0.000252	CcSEcCtD
Levetiracetam—Abdominal pain—Docetaxel—prostate cancer	5.95e-05	0.000252	CcSEcCtD
Levetiracetam—SV2A—Disease—APC—prostate cancer	5.94e-05	0.00034	CbGpPWpGaD
Levetiracetam—Musculoskeletal discomfort—Prednisone—prostate cancer	5.91e-05	0.00025	CcSEcCtD
Levetiracetam—Insomnia—Prednisone—prostate cancer	5.87e-05	0.000249	CcSEcCtD
Levetiracetam—SV2A—Disease—IRS1—prostate cancer	5.87e-05	0.000336	CbGpPWpGaD
Levetiracetam—SV2A—Disease—EGF—prostate cancer	5.87e-05	0.000336	CbGpPWpGaD
Levetiracetam—Vision blurred—Epirubicin—prostate cancer	5.86e-05	0.000248	CcSEcCtD
Levetiracetam—Alopecia—Doxorubicin—prostate cancer	5.84e-05	0.000247	CcSEcCtD
Levetiracetam—Paraesthesia—Prednisone—prostate cancer	5.83e-05	0.000247	CcSEcCtD
Levetiracetam—Mental disorder—Doxorubicin—prostate cancer	5.79e-05	0.000245	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—TERT—prostate cancer	5.79e-05	0.000332	CbGpPWpGaD
Levetiracetam—Abdominal pain—Capecitabine—prostate cancer	5.76e-05	0.000244	CcSEcCtD
Levetiracetam—Body temperature increased—Capecitabine—prostate cancer	5.76e-05	0.000244	CcSEcCtD
Levetiracetam—Vomiting—Etoposide—prostate cancer	5.76e-05	0.000244	CcSEcCtD
Levetiracetam—Malnutrition—Doxorubicin—prostate cancer	5.76e-05	0.000244	CcSEcCtD
Levetiracetam—Agitation—Epirubicin—prostate cancer	5.72e-05	0.000242	CcSEcCtD
Levetiracetam—Dyspepsia—Prednisone—prostate cancer	5.71e-05	0.000242	CcSEcCtD
Levetiracetam—Rash—Etoposide—prostate cancer	5.71e-05	0.000242	CcSEcCtD
Levetiracetam—Dermatitis—Etoposide—prostate cancer	5.71e-05	0.000242	CcSEcCtD
Levetiracetam—SV2A—Disease—GSK3B—prostate cancer	5.7e-05	0.000326	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL10—prostate cancer	5.69e-05	0.000326	CbGpPWpGaD
Levetiracetam—Headache—Etoposide—prostate cancer	5.67e-05	0.00024	CcSEcCtD
Levetiracetam—Tension—Doxorubicin—prostate cancer	5.65e-05	0.000239	CcSEcCtD
Levetiracetam—Decreased appetite—Prednisone—prostate cancer	5.64e-05	0.000239	CcSEcCtD
Levetiracetam—SV2A—Disease—INS—prostate cancer	5.62e-05	0.000322	CbGpPWpGaD
Levetiracetam—Fatigue—Prednisone—prostate cancer	5.6e-05	0.000237	CcSEcCtD
Levetiracetam—Nervousness—Doxorubicin—prostate cancer	5.59e-05	0.000237	CcSEcCtD
Levetiracetam—Vertigo—Epirubicin—prostate cancer	5.59e-05	0.000237	CcSEcCtD
Levetiracetam—Leukopenia—Epirubicin—prostate cancer	5.57e-05	0.000236	CcSEcCtD
Levetiracetam—Back pain—Doxorubicin—prostate cancer	5.57e-05	0.000236	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—HSP90AB1—prostate cancer	5.56e-05	0.000319	CbGpPWpGaD
Levetiracetam—Constipation—Prednisone—prostate cancer	5.55e-05	0.000235	CcSEcCtD
Levetiracetam—Hypersensitivity—Docetaxel—prostate cancer	5.55e-05	0.000235	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—HIF1A—prostate cancer	5.54e-05	0.000317	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CREBBP—prostate cancer	5.51e-05	0.000315	CbGpPWpGaD
Levetiracetam—Cough—Epirubicin—prostate cancer	5.43e-05	0.00023	CcSEcCtD
Levetiracetam—Vision blurred—Doxorubicin—prostate cancer	5.42e-05	0.00023	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—LEP—prostate cancer	5.41e-05	0.00031	CbGpPWpGaD
Levetiracetam—Asthenia—Docetaxel—prostate cancer	5.4e-05	0.000229	CcSEcCtD
Levetiracetam—Convulsion—Epirubicin—prostate cancer	5.39e-05	0.000228	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	5.39e-05	0.000308	CbGpPWpGaD
Levetiracetam—Nausea—Etoposide—prostate cancer	5.38e-05	0.000228	CcSEcCtD
Levetiracetam—Hypersensitivity—Capecitabine—prostate cancer	5.37e-05	0.000227	CcSEcCtD
Levetiracetam—Feeling abnormal—Prednisone—prostate cancer	5.35e-05	0.000226	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—prostate cancer	5.35e-05	0.000306	CbGpPWpGaD
Levetiracetam—Pruritus—Docetaxel—prostate cancer	5.33e-05	0.000225	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Prednisone—prostate cancer	5.31e-05	0.000225	CcSEcCtD
Levetiracetam—Myalgia—Epirubicin—prostate cancer	5.3e-05	0.000224	CcSEcCtD
Levetiracetam—Arthralgia—Epirubicin—prostate cancer	5.3e-05	0.000224	CcSEcCtD
Levetiracetam—Chest pain—Epirubicin—prostate cancer	5.3e-05	0.000224	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—FASLG—prostate cancer	5.29e-05	0.000303	CbGpPWpGaD
Levetiracetam—Agitation—Doxorubicin—prostate cancer	5.29e-05	0.000224	CcSEcCtD
Levetiracetam—Anxiety—Epirubicin—prostate cancer	5.28e-05	0.000223	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	5.26e-05	0.000223	CcSEcCtD
Levetiracetam—SV2A—Disease—MAP2K1—prostate cancer	5.26e-05	0.000301	CbGpPWpGaD
Levetiracetam—Asthenia—Capecitabine—prostate cancer	5.23e-05	0.000221	CcSEcCtD
Levetiracetam—SV2A—Disease—PIK3CD—prostate cancer	5.22e-05	0.000299	CbGpPWpGaD
Levetiracetam—Vertigo—Doxorubicin—prostate cancer	5.17e-05	0.000219	CcSEcCtD
Levetiracetam—SV2A—Disease—SERPINE1—prostate cancer	5.16e-05	0.000296	CbGpPWpGaD
Levetiracetam—Pruritus—Capecitabine—prostate cancer	5.16e-05	0.000218	CcSEcCtD
Levetiracetam—Leukopenia—Doxorubicin—prostate cancer	5.15e-05	0.000218	CcSEcCtD
Levetiracetam—Diarrhoea—Docetaxel—prostate cancer	5.15e-05	0.000218	CcSEcCtD
Levetiracetam—Abdominal pain—Prednisone—prostate cancer	5.13e-05	0.000217	CcSEcCtD
Levetiracetam—Body temperature increased—Prednisone—prostate cancer	5.13e-05	0.000217	CcSEcCtD
Levetiracetam—Confusional state—Epirubicin—prostate cancer	5.12e-05	0.000217	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—prostate cancer	5.07e-05	0.00029	CbGpPWpGaD
Levetiracetam—Infection—Epirubicin—prostate cancer	5.04e-05	0.000214	CcSEcCtD
Levetiracetam—Cough—Doxorubicin—prostate cancer	5.02e-05	0.000213	CcSEcCtD
Levetiracetam—SV2A—Disease—FGF2—prostate cancer	5e-05	0.000286	CbGpPWpGaD
Levetiracetam—Convulsion—Doxorubicin—prostate cancer	4.99e-05	0.000211	CcSEcCtD
Levetiracetam—Diarrhoea—Capecitabine—prostate cancer	4.99e-05	0.000211	CcSEcCtD
Levetiracetam—Nervous system disorder—Epirubicin—prostate cancer	4.98e-05	0.000211	CcSEcCtD
Levetiracetam—Dizziness—Docetaxel—prostate cancer	4.98e-05	0.000211	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	4.97e-05	0.000285	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCG5—prostate cancer	4.97e-05	0.000285	CbGpPWpGaD
Levetiracetam—Thrombocytopenia—Epirubicin—prostate cancer	4.97e-05	0.00021	CcSEcCtD
Levetiracetam—Skin disorder—Epirubicin—prostate cancer	4.93e-05	0.000209	CcSEcCtD
Levetiracetam—SV2A—Disease—NOS3—prostate cancer	4.93e-05	0.000282	CbGpPWpGaD
Levetiracetam—Myalgia—Doxorubicin—prostate cancer	4.9e-05	0.000207	CcSEcCtD
Levetiracetam—Chest pain—Doxorubicin—prostate cancer	4.9e-05	0.000207	CcSEcCtD
Levetiracetam—Arthralgia—Doxorubicin—prostate cancer	4.9e-05	0.000207	CcSEcCtD
Levetiracetam—Anxiety—Doxorubicin—prostate cancer	4.88e-05	0.000207	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.87e-05	0.000206	CcSEcCtD
Levetiracetam—Anorexia—Epirubicin—prostate cancer	4.84e-05	0.000205	CcSEcCtD
Levetiracetam—Dizziness—Capecitabine—prostate cancer	4.82e-05	0.000204	CcSEcCtD
Levetiracetam—SV2A—Disease—JAK2—prostate cancer	4.79e-05	0.000274	CbGpPWpGaD
Levetiracetam—Vomiting—Docetaxel—prostate cancer	4.79e-05	0.000203	CcSEcCtD
Levetiracetam—Hypersensitivity—Prednisone—prostate cancer	4.78e-05	0.000202	CcSEcCtD
Levetiracetam—Rash—Docetaxel—prostate cancer	4.75e-05	0.000201	CcSEcCtD
Levetiracetam—Dermatitis—Docetaxel—prostate cancer	4.74e-05	0.000201	CcSEcCtD
Levetiracetam—Confusional state—Doxorubicin—prostate cancer	4.74e-05	0.000201	CcSEcCtD
Levetiracetam—Headache—Docetaxel—prostate cancer	4.72e-05	0.0002	CcSEcCtD
Levetiracetam—SV2A—Disease—MDM2—prostate cancer	4.68e-05	0.000268	CbGpPWpGaD
Levetiracetam—Infection—Doxorubicin—prostate cancer	4.67e-05	0.000198	CcSEcCtD
Levetiracetam—Asthenia—Prednisone—prostate cancer	4.66e-05	0.000197	CcSEcCtD
Levetiracetam—Vomiting—Capecitabine—prostate cancer	4.63e-05	0.000196	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Epirubicin—prostate cancer	4.63e-05	0.000196	CcSEcCtD
Levetiracetam—SV2A—Disease—ERBB2—prostate cancer	4.61e-05	0.000264	CbGpPWpGaD
Levetiracetam—Nervous system disorder—Doxorubicin—prostate cancer	4.61e-05	0.000195	CcSEcCtD
Levetiracetam—Thrombocytopenia—Doxorubicin—prostate cancer	4.6e-05	0.000195	CcSEcCtD
Levetiracetam—Rash—Capecitabine—prostate cancer	4.6e-05	0.000195	CcSEcCtD
Levetiracetam—Pruritus—Prednisone—prostate cancer	4.59e-05	0.000194	CcSEcCtD
Levetiracetam—Insomnia—Epirubicin—prostate cancer	4.59e-05	0.000194	CcSEcCtD
Levetiracetam—Dermatitis—Capecitabine—prostate cancer	4.59e-05	0.000194	CcSEcCtD
Levetiracetam—Headache—Capecitabine—prostate cancer	4.57e-05	0.000193	CcSEcCtD
Levetiracetam—Skin disorder—Doxorubicin—prostate cancer	4.56e-05	0.000193	CcSEcCtD
Levetiracetam—Paraesthesia—Epirubicin—prostate cancer	4.56e-05	0.000193	CcSEcCtD
Levetiracetam—SV2A—Disease—PIK3CB—prostate cancer	4.55e-05	0.000261	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—prostate cancer	4.55e-05	0.00026	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—CREBBP—prostate cancer	4.52e-05	0.000259	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—prostate cancer	4.52e-05	0.000259	CbGpPWpGaD
Levetiracetam—Somnolence—Epirubicin—prostate cancer	4.51e-05	0.000191	CcSEcCtD
Levetiracetam—SV2A—Disease—PTGS2—prostate cancer	4.51e-05	0.000258	CbGpPWpGaD
Levetiracetam—Anorexia—Doxorubicin—prostate cancer	4.48e-05	0.00019	CcSEcCtD
Levetiracetam—Nausea—Docetaxel—prostate cancer	4.47e-05	0.000189	CcSEcCtD
Levetiracetam—Dyspepsia—Epirubicin—prostate cancer	4.47e-05	0.000189	CcSEcCtD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—prostate cancer	4.45e-05	0.000255	CbGpPWpGaD
Levetiracetam—Diarrhoea—Prednisone—prostate cancer	4.44e-05	0.000188	CcSEcCtD
Levetiracetam—Decreased appetite—Epirubicin—prostate cancer	4.41e-05	0.000187	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—prostate cancer	4.41e-05	0.000252	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	4.39e-05	0.000251	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Epirubicin—prostate cancer	4.38e-05	0.000186	CcSEcCtD
Levetiracetam—Fatigue—Epirubicin—prostate cancer	4.38e-05	0.000185	CcSEcCtD
Levetiracetam—Constipation—Epirubicin—prostate cancer	4.34e-05	0.000184	CcSEcCtD
Levetiracetam—Pain—Epirubicin—prostate cancer	4.34e-05	0.000184	CcSEcCtD
Levetiracetam—Nausea—Capecitabine—prostate cancer	4.33e-05	0.000183	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—prostate cancer	4.31e-05	0.000247	CbGpPWpGaD
Levetiracetam—Dizziness—Prednisone—prostate cancer	4.29e-05	0.000182	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.28e-05	0.000181	CcSEcCtD
Levetiracetam—SV2A—Disease—CDKN1B—prostate cancer	4.27e-05	0.000245	CbGpPWpGaD
Levetiracetam—Insomnia—Doxorubicin—prostate cancer	4.25e-05	0.00018	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—prostate cancer	4.24e-05	0.000243	CbGpPWpGaD
Levetiracetam—Paraesthesia—Doxorubicin—prostate cancer	4.22e-05	0.000179	CcSEcCtD
Levetiracetam—Feeling abnormal—Epirubicin—prostate cancer	4.18e-05	0.000177	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—GNG5—prostate cancer	4.18e-05	0.000239	CbGpPWpGaD
Levetiracetam—Somnolence—Doxorubicin—prostate cancer	4.18e-05	0.000177	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Epirubicin—prostate cancer	4.15e-05	0.000176	CcSEcCtD
Levetiracetam—Dyspepsia—Doxorubicin—prostate cancer	4.14e-05	0.000175	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—prostate cancer	4.13e-05	0.000237	CbGpPWpGaD
Levetiracetam—Vomiting—Prednisone—prostate cancer	4.13e-05	0.000175	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—THBS1—prostate cancer	4.11e-05	0.000235	CbGpPWpGaD
Levetiracetam—Rash—Prednisone—prostate cancer	4.09e-05	0.000173	CcSEcCtD
Levetiracetam—Dermatitis—Prednisone—prostate cancer	4.09e-05	0.000173	CcSEcCtD
Levetiracetam—Decreased appetite—Doxorubicin—prostate cancer	4.08e-05	0.000173	CcSEcCtD
Levetiracetam—Headache—Prednisone—prostate cancer	4.07e-05	0.000172	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.06e-05	0.000172	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—prostate cancer	4.05e-05	0.000232	CbGpPWpGaD
Levetiracetam—Fatigue—Doxorubicin—prostate cancer	4.05e-05	0.000171	CcSEcCtD
Levetiracetam—SV2A—Disease—CTNNB1—prostate cancer	4.03e-05	0.000231	CbGpPWpGaD
Levetiracetam—Constipation—Doxorubicin—prostate cancer	4.02e-05	0.00017	CcSEcCtD
Levetiracetam—Pain—Doxorubicin—prostate cancer	4.02e-05	0.00017	CcSEcCtD
Levetiracetam—Abdominal pain—Epirubicin—prostate cancer	4.01e-05	0.00017	CcSEcCtD
Levetiracetam—Body temperature increased—Epirubicin—prostate cancer	4.01e-05	0.00017	CcSEcCtD
Levetiracetam—SV2A—Disease—CDKN1A—prostate cancer	3.94e-05	0.000226	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTEN—prostate cancer	3.93e-05	0.000225	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	3.93e-05	0.000225	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—prostate cancer	3.92e-05	0.000225	CbGpPWpGaD
Levetiracetam—Feeling abnormal—Doxorubicin—prostate cancer	3.87e-05	0.000164	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—prostate cancer	3.86e-05	0.000221	CbGpPWpGaD
Levetiracetam—Nausea—Prednisone—prostate cancer	3.86e-05	0.000163	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Doxorubicin—prostate cancer	3.84e-05	0.000163	CcSEcCtD
Levetiracetam—SV2A—Disease—EP300—prostate cancer	3.75e-05	0.000215	CbGpPWpGaD
Levetiracetam—Hypersensitivity—Epirubicin—prostate cancer	3.74e-05	0.000158	CcSEcCtD
Levetiracetam—Body temperature increased—Doxorubicin—prostate cancer	3.71e-05	0.000157	CcSEcCtD
Levetiracetam—Abdominal pain—Doxorubicin—prostate cancer	3.71e-05	0.000157	CcSEcCtD
Levetiracetam—SV2A—Disease—SRC—prostate cancer	3.65e-05	0.000209	CbGpPWpGaD
Levetiracetam—Asthenia—Epirubicin—prostate cancer	3.64e-05	0.000154	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—prostate cancer	3.64e-05	0.000208	CbGpPWpGaD
Levetiracetam—Pruritus—Epirubicin—prostate cancer	3.59e-05	0.000152	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—PRKACB—prostate cancer	3.56e-05	0.000204	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—prostate cancer	3.52e-05	0.000202	CbGpPWpGaD
Levetiracetam—SV2A—Disease—STAT3—prostate cancer	3.52e-05	0.000201	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—prostate cancer	3.49e-05	0.0002	CbGpPWpGaD
Levetiracetam—Diarrhoea—Epirubicin—prostate cancer	3.47e-05	0.000147	CcSEcCtD
Levetiracetam—Hypersensitivity—Doxorubicin—prostate cancer	3.46e-05	0.000147	CcSEcCtD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—prostate cancer	3.41e-05	0.000195	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—prostate cancer	3.4e-05	0.000195	CbGpPWpGaD
Levetiracetam—Asthenia—Doxorubicin—prostate cancer	3.37e-05	0.000143	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—NCOA2—prostate cancer	3.36e-05	0.000192	CbGpPWpGaD
Levetiracetam—Dizziness—Epirubicin—prostate cancer	3.36e-05	0.000142	CcSEcCtD
Levetiracetam—Pruritus—Doxorubicin—prostate cancer	3.32e-05	0.000141	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—prostate cancer	3.3e-05	0.000189	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MYC—prostate cancer	3.27e-05	0.000187	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TGFB1—prostate cancer	3.26e-05	0.000187	CbGpPWpGaD
Levetiracetam—Vomiting—Epirubicin—prostate cancer	3.23e-05	0.000137	CcSEcCtD
Levetiracetam—Diarrhoea—Doxorubicin—prostate cancer	3.21e-05	0.000136	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—AR—prostate cancer	3.21e-05	0.000184	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	3.2e-05	0.000183	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	3.2e-05	0.000183	CbGpPWpGaD
Levetiracetam—Rash—Epirubicin—prostate cancer	3.2e-05	0.000136	CcSEcCtD
Levetiracetam—Dermatitis—Epirubicin—prostate cancer	3.2e-05	0.000135	CcSEcCtD
Levetiracetam—SV2A—Disease—EGFR—prostate cancer	3.2e-05	0.000183	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—prostate cancer	3.19e-05	0.000182	CbGpPWpGaD
Levetiracetam—Headache—Epirubicin—prostate cancer	3.18e-05	0.000135	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	3.12e-05	0.000179	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	3.12e-05	0.000179	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CXCL8—prostate cancer	3.11e-05	0.000178	CbGpPWpGaD
Levetiracetam—Dizziness—Doxorubicin—prostate cancer	3.11e-05	0.000132	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—EP300—prostate cancer	3.08e-05	0.000176	CbGpPWpGaD
Levetiracetam—SV2A—Disease—KRAS—prostate cancer	3.02e-05	0.000173	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—TGFB1—prostate cancer	3.02e-05	0.000173	CbGpPWpGaD
Levetiracetam—Nausea—Epirubicin—prostate cancer	3.02e-05	0.000128	CcSEcCtD
Levetiracetam—Vomiting—Doxorubicin—prostate cancer	2.99e-05	0.000126	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—prostate cancer	2.99e-05	0.000171	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CASP3—prostate cancer	2.98e-05	0.000171	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL2—prostate cancer	2.97e-05	0.00017	CbGpPWpGaD
Levetiracetam—Rash—Doxorubicin—prostate cancer	2.96e-05	0.000125	CcSEcCtD
Levetiracetam—Dermatitis—Doxorubicin—prostate cancer	2.96e-05	0.000125	CcSEcCtD
Levetiracetam—Headache—Doxorubicin—prostate cancer	2.94e-05	0.000125	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—prostate cancer	2.93e-05	0.000168	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—prostate cancer	2.92e-05	0.000167	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HAO1—prostate cancer	2.86e-05	0.000164	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—prostate cancer	2.84e-05	0.000163	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.83e-05	0.000162	CbGpPWpGaD
Levetiracetam—Nausea—Doxorubicin—prostate cancer	2.79e-05	0.000118	CcSEcCtD
Levetiracetam—SV2A—Disease—PIK3CA—prostate cancer	2.77e-05	0.000159	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—prostate cancer	2.74e-05	0.000157	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—RXRA—prostate cancer	2.69e-05	0.000154	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—prostate cancer	2.61e-05	0.000149	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	2.53e-05	0.000145	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—VEGFA—prostate cancer	2.53e-05	0.000145	CbGpPWpGaD
Levetiracetam—SV2A—Disease—IL6—prostate cancer	2.46e-05	0.000141	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCG5—prostate cancer	2.34e-05	0.000134	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PSAT1—prostate cancer	2.33e-05	0.000133	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—TST—prostate cancer	2.33e-05	0.000133	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CBR1—prostate cancer	2.33e-05	0.000133	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ADI1—prostate cancer	2.33e-05	0.000133	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CSAD—prostate cancer	2.33e-05	0.000133	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GRHL1—prostate cancer	2.33e-05	0.000133	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TGFB1—prostate cancer	2.32e-05	0.000133	CbGpPWpGaD
Levetiracetam—SV2A—Disease—AKT1—prostate cancer	2.27e-05	0.00013	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	2.22e-05	0.000127	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	2.21e-05	0.000126	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—UGT2B15—prostate cancer	2.17e-05	0.000124	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CKMT2—prostate cancer	2.17e-05	0.000124	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GRHPR—prostate cancer	2.17e-05	0.000124	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—UGT2B17—prostate cancer	2.17e-05	0.000124	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	2.15e-05	0.000123	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	2.09e-05	0.000119	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	2.06e-05	0.000118	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	2.06e-05	0.000118	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—PPARA—prostate cancer	2.06e-05	0.000118	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—RFK—prostate cancer	2.04e-05	0.000117	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PGAM2—prostate cancer	2.04e-05	0.000117	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NAGLU—prostate cancer	2.04e-05	0.000117	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SULT2B1—prostate cancer	2.04e-05	0.000117	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MBTPS1—prostate cancer	2.04e-05	0.000117	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AOX1—prostate cancer	2.04e-05	0.000117	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTM3—prostate cancer	2.04e-05	0.000117	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—GNG5—prostate cancer	1.96e-05	0.000112	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	1.93e-05	0.000111	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AMACR—prostate cancer	1.93e-05	0.00011	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP3A43—prostate cancer	1.93e-05	0.00011	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—DEGS1—prostate cancer	1.93e-05	0.00011	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NAT1—prostate cancer	1.93e-05	0.00011	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SRD5A2—prostate cancer	1.93e-05	0.00011	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	1.91e-05	0.000109	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—AKT1—prostate cancer	1.86e-05	0.000107	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	1.85e-05	0.000106	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HSD17B1—prostate cancer	1.84e-05	0.000105	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	1.76e-05	0.0001	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.67e-05	9.59e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	1.67e-05	9.54e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	1.64e-05	9.4e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—B4GALT4—prostate cancer	1.64e-05	9.39e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HPGD—prostate cancer	1.64e-05	9.39e-05	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.63e-05	9.35e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	1.62e-05	9.27e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	1.58e-05	9.06e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.58e-05	9.04e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—TNFRSF21—prostate cancer	1.54e-05	8.83e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.51e-05	8.62e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP7B1—prostate cancer	1.5e-05	8.59e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MTAP—prostate cancer	1.5e-05	8.59e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	1.5e-05	8.59e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	1.47e-05	8.41e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SULT1E1—prostate cancer	1.46e-05	8.37e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SRD5A1—prostate cancer	1.46e-05	8.37e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	1.43e-05	8.19e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	1.42e-05	8.11e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ACSL4—prostate cancer	1.4e-05	7.99e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HSD17B3—prostate cancer	1.4e-05	7.99e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	1.38e-05	7.92e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	1.38e-05	7.9e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ARG2—prostate cancer	1.34e-05	7.66e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—UMPS—prostate cancer	1.34e-05	7.66e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PHGDH—prostate cancer	1.34e-05	7.66e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.33e-05	7.62e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	1.32e-05	7.54e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LDHB—prostate cancer	1.31e-05	7.51e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP3A5—prostate cancer	1.29e-05	7.37e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	1.28e-05	7.33e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	1.27e-05	7.25e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	1.25e-05	7.14e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PDHA1—prostate cancer	1.24e-05	7.12e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—TCN2—prostate cancer	1.24e-05	7.12e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—UCP3—prostate cancer	1.24e-05	7.12e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTA3—prostate cancer	1.24e-05	7.12e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HSD3B1—prostate cancer	1.19e-05	6.79e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC22A3—prostate cancer	1.19e-05	6.79e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	1.15e-05	6.57e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	1.14e-05	6.55e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTA4—prostate cancer	1.14e-05	6.51e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—TBXAS1—prostate cancer	1.14e-05	6.51e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.12e-05	6.43e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTA2—prostate cancer	1.11e-05	6.35e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SULT1A1—prostate cancer	1.09e-05	6.27e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCG5—prostate cancer	1.09e-05	6.27e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTA1—prostate cancer	1.07e-05	6.12e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	1.06e-05	6.07e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NAT2—prostate cancer	1.06e-05	6.05e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTO1—prostate cancer	1.06e-05	6.05e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HSD3B2—prostate cancer	1.06e-05	6.05e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PLCB2—prostate cancer	1.01e-05	5.8e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2C18—prostate cancer	1.01e-05	5.8e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LRP2—prostate cancer	1.01e-05	5.8e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—P4HB—prostate cancer	9.94e-06	5.69e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	9.74e-06	5.58e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC22A1—prostate cancer	9.67e-06	5.54e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	9.67e-06	5.54e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SULT2A1—prostate cancer	9.42e-06	5.4e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	9.42e-06	5.39e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MED12—prostate cancer	9.27e-06	5.31e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GNG5—prostate cancer	9.2e-06	5.27e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NCOA3—prostate cancer	8.86e-06	5.07e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HPGDS—prostate cancer	8.45e-06	4.84e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2C19—prostate cancer	8.4e-06	4.81e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTT1—prostate cancer	8.2e-06	4.69e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ACHE—prostate cancer	8.2e-06	4.69e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2A6—prostate cancer	8.1e-06	4.64e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	7.96e-06	4.56e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AKR1C3—prostate cancer	7.88e-06	4.51e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PRKACB—prostate cancer	7.84e-06	4.49e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP17A1—prostate cancer	7.76e-06	4.44e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	7.68e-06	4.4e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NCOA2—prostate cancer	7.39e-06	4.23e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC5A5—prostate cancer	7.05e-06	4.04e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2E1—prostate cancer	6.89e-06	3.95e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NQO1—prostate cancer	6.81e-06	3.9e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—TH—prostate cancer	6.71e-06	3.84e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP3A4—prostate cancer	6.64e-06	3.8e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP1B1—prostate cancer	6.53e-06	3.74e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GGT1—prostate cancer	6.33e-06	3.62e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NCOA1—prostate cancer	6.23e-06	3.57e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP19A1—prostate cancer	6.14e-06	3.52e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—RXRA—prostate cancer	5.93e-06	3.39e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—COMT—prostate cancer	5.71e-06	3.27e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTP1—prostate cancer	5.68e-06	3.25e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ITPR1—prostate cancer	5.59e-06	3.2e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—TYMS—prostate cancer	5.28e-06	3.02e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTM1—prostate cancer	5.22e-06	2.99e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LPL—prostate cancer	5.13e-06	2.93e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP1A1—prostate cancer	4.95e-06	2.83e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ERCC2—prostate cancer	4.91e-06	2.81e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MTHFR—prostate cancer	4.62e-06	2.64e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPARA—prostate cancer	4.53e-06	2.59e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CAV1—prostate cancer	4.26e-06	2.44e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CG—prostate cancer	3.88e-06	2.22e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—INS—prostate cancer	3.67e-06	2.1e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CREBBP—prostate cancer	3.6e-06	2.06e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CD—prostate cancer	3.41e-06	1.95e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NOS3—prostate cancer	3.22e-06	1.84e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CB—prostate cancer	2.97e-06	1.7e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGS2—prostate cancer	2.94e-06	1.69e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTEN—prostate cancer	2.57e-06	1.47e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—EP300—prostate cancer	2.45e-06	1.4e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CA—prostate cancer	1.81e-06	1.04e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AKT1—prostate cancer	1.48e-06	8.47e-06	CbGpPWpGaD
